These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 16320857)

  • 1. Glucomannan and obesity: a critical review.
    Keithley J; Swanson B
    Altern Ther Health Med; 2005; 11(6):30-4. PubMed ID: 16320857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of glucomannan on body weight in overweight or obese children and adults: a systematic review of randomized controlled trials.
    Zalewski BM; Chmielewska A; Szajewska H
    Nutrition; 2015 Mar; 31(3):437-42.e2. PubMed ID: 25701331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy of glucomannan supplementation in overweight and obesity: a systematic review and meta-analysis of randomized clinical trials.
    Onakpoya I; Posadzki P; Ernst E
    J Am Coll Nutr; 2014; 33(1):70-8. PubMed ID: 24533610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of glucomannan on obese patients: a clinical study.
    Walsh DE; Yaghoubian V; Behforooz A
    Int J Obes; 1984; 8(4):289-93. PubMed ID: 6096282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Glucomannan: properties and therapeutic applications].
    González Canga A; Fernández Martínez N; Sahagún AM; García Vieitez JJ; Díez Liébana MJ; Calle Pardo AP; Castro Robles LJ; Sierra Vega M
    Nutr Hosp; 2004; 19(1):45-50. PubMed ID: 14983741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correction of data errors and reanalysis of "The effect of glucomannan on body weight in overweight or obese children and adults: a systematic review of randomized controlled trials".
    Zalewski BM; Chmielewska A; Szajewska H; Keithley JK; Li P; Goldsby TU; Allison DB
    Nutrition; 2015; 31(7-8):1056-7. PubMed ID: 26059384
    [No Abstract]   [Full Text] [Related]  

  • 7. [Chronic use of glucomannan in the dietary treatment of severe obesity].
    Vita PM; Restelli A; Caspani P; Klinger R
    Minerva Med; 1992 Mar; 83(3):135-9. PubMed ID: 1313163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Weight Maintenance with Litramine (IQP-G-002AS): A 24-Week Double-Blind, Randomized, Placebo-Controlled Study.
    Grube B; Chong PW; Alt F; Uebelhack R
    J Obes; 2015; 2015():953138. PubMed ID: 26435849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experiences with three different fiber supplements in weight reduction.
    Birketvedt GS; Shimshi M; Erling T; Florholmen J
    Med Sci Monit; 2005 Jan; 11(1):PI5-8. PubMed ID: 15614200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of metformin for weight management in patients without type 2 diabetes.
    Desilets AR; Dhakal-Karki S; Dunican KC
    Ann Pharmacother; 2008 Jun; 42(6):817-26. PubMed ID: 18477733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of glucomannan for weight loss in overweight and moderately obese adults.
    Keithley JK; Swanson B; Mikolaitis SL; DeMeo M; Zeller JM; Fogg L; Adamji J
    J Obes; 2013; 2013():610908. PubMed ID: 24490058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of glucomannan supplementation on body weight in overweight and obese children: protocol of a randomised controlled trial.
    Zalewski BM; Szajewska H
    BMJ Open; 2015 Apr; 5(4):e007244. PubMed ID: 25869689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ability of konjac-glucomannan to suppress spontaneously occurring dermatitis in NC/Nga mice depends upon the particle size.
    Onishi N; Kawamoto S; Nishimura M; Nakano T; Aki T; Shigeta S; Shimizu H; Hashimoto K; Ono K
    Biofactors; 2004; 21(1-4):163-6. PubMed ID: 15630191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exenatide as a novel weight loss modality in patients without diabetes.
    Moreno JL; Willett KC; Desilets AR
    Ann Pharmacother; 2012 Dec; 46(12):1700-6. PubMed ID: 23191935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of pramlintide for weight loss.
    Dunican KC; Adams NM; Desilets AR
    Ann Pharmacother; 2010 Mar; 44(3):538-45. PubMed ID: 20164472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of the action of glucomannan on metabolic parameters and on the sensation of satiation in overweight and obese patients].
    Cairella M; Marchini G
    Clin Ter; 1995 Apr; 146(4):269-74. PubMed ID: 7796558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sibutramine--a review of clinical efficacy.
    Lean ME
    Int J Obes Relat Metab Disord; 1997 Mar; 21 Suppl 1():S30-6; discussion 37-9. PubMed ID: 9130039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of two doses of a mixture of soluble fibres on body weight and metabolic variables in overweight or obese patients: a randomised trial.
    Salas-Salvadó J; Farrés X; Luque X; Narejos S; Borrell M; Basora J; Anguera A; Torres F; Bulló M; Balanza R;
    Br J Nutr; 2008 Jun; 99(6):1380-7. PubMed ID: 18031592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formulary management of 2 new agents: lorcaserin and phentermine/topiramate for weight loss.
    Kelly EM; Tungol AA; Wesolowicz LA
    J Manag Care Pharm; 2013 Oct; 19(8):642-54. PubMed ID: 24074010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phentermine, topiramate and their combination for the treatment of adiposopathy ('sick fat') and metabolic disease.
    Bays H
    Expert Rev Cardiovasc Ther; 2010 Dec; 8(12):1777-801. PubMed ID: 20707765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.